← Back

MicroPort Endovascular MedTech Ltd

85.48-23.4%1Y · CNY

Shanghai MicroPort Endovascular MedTech Co., Ltd. develops, manufactures, sells, and services aortic, peripheral vascular, and tumor intervention devices in China and internationally. Its product portfolio includes stent graft systems such as Fontus, CRONUS, Hector, Cratos, Castor, Talos, Hercules, Minos, Aegis, and Altura, as well as the Aorfix endovascular device and the L-REBOA aortic occlusion balloon catheter. The company also offers peripheral vascular products including Reewarm PTX, ReeAmber, Reewarm, Ryflumen, CROWNUS, HawkMaster, HawkNest, Veryan BM3D, Vflower, SeaDragon, Vewatch, Vepack, VeinPro, Reflow-speX, and DEMANTOID, along with the Tipspear transjugular liver access set. Incorporated in 2012, it is based in Shanghai, China.

Price · split & dividend adjusted
News & notes moving 688016.CG
688016.CG▲3

Endovastec's 2026 interim report shows net profit of 322 million yuan

Endovastec released its 2026 interim report, with total operating revenue of 794 million yuan and net profit attributable to the parent company of 322 million yuan. Net cash inflow from operating activities was 290 million yuan, down 9.11% from the same period last year. The company's asset-liability ratio was 13.72%, gross margin was 71.36%, ROE was 7.57%, and diluted earnings per share was 2.67 yuan. The number of shareholders was 16,200, and the top ten shareholders held 46.51% of the total share capital.
688016.CG · Capital · Positive Company reports net profit of 322 million yuan on revenue of 794 million, indicating strong financial performance.
Read original ↗
Jiemian·40dRead more →
China
688016.CG▲

Endovastec Plans Cash Dividend of 13 Yuan per 10 Shares

Endovastec announced on August 26 that it plans to distribute a cash dividend of 13 yuan, tax included, for every 10 shares to all shareholders, with total dividends expected to reach 157 million yuan, accounting for 48.73% of net profit attributable to the parent company in the first half of 2026. In the interim period of 2026, the company achieved revenue of 794 million yuan and net profit attributable to the parent company of 322 million yuan.
688016.CG · Capital · Positive Plans cash dividend of 13 yuan per 10 shares, distributing 48.73% of H1 2026 net profit.
Read original ↗
财中社·41dRead more →
China
688016.CG▲

Multiple A-share companies announce hefty dividends; Deye plans 16 yuan per 10 shares

On the evening of August 26, several A-share companies disclosed hefty dividend plans. Energy storage leader Deye plans to distribute 16 yuan in cash per 10 shares, totaling 2.037 billion yuan, representing 74.97% of net profit attributable to shareholders for the period. In the first half, the company achieved revenue of 10.641 billion yuan, up 92.23% year on year, with net profit attributable to shareholders of 2.717 billion yuan, up 78.53%. MicroPort Endovascular MedTech plans to distribute 13 yuan per 10 shares, totaling 157 million yuan, or 48.73% of first-half net profit attributable to shareholders. Giant Network plans to distribute 8 yuan per 10 shares, totaling 1.515 billion yuan, or 70.65% of net profit, and also released a shareholder dividend return plan for the next three years. NARI Technology plans to distribute 1.53 yuan per 10 shares, totaling 1.222 billion yuan, with first-half dividends and buybacks combined at 1.261 billion yuan, or 41.03% of net profit attributable to shareholders for the same period. In addition, China CITIC Bank plans to distribute 2.03 yuan per 10 shares, totaling 11.296 billion yuan; New China Life Insurance plans to distribute 7.3 yuan per 10 shares, totaling 2.277 billion yuan; Anhui Conch Cement plans to distribute 1.3 yuan per 10 shares, totaling 680 million yuan; Sinotruk plans to distribute 5.41 yuan per 10 shares, totaling 632 million yuan; Haisco Pharmaceutical plans to distribute 5.26 yuan per 10 shares, totaling 600 million yuan.
605117.CG · Capital · Positive Plans dividend of 16 yuan per 10 shares, totaling 2.037 billion yuan, 74.97% of net profit.
000951.CS · Capital · Positive Plans to distribute 5.41 yuan per 10 shares, totaling 632 million yuan.
002558.CS · Capital · Positive Plans to distribute 8 yuan per 10 shares, totaling 1.515 billion yuan, 70.65% of net profit, and released a three-year dividend return plan.
002653.CS · Capital · Positive Plans to distribute 5.26 yuan per 10 shares, totaling 600 million yuan.
688016.CG · Capital · Positive Plans to distribute 13 yuan per 10 shares, totaling 157 million yuan, 48.73% of first-half net profit.
600406.CG · Capital · Positive Plans dividend of 1.53 yuan per 10 shares and buybacks, returning 41.03% of net profit.
Read original ↗
证券时报·41dRead more →